NCT02254824

Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients

Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients (EMINENT Study)

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of EMINENT study is to evaluate the efficacy of Xuezhikang or atorvastatin in hypertensive patients at low/moderate cardiovascular risk.

Detailed description

EMINENT study is to evaluate the efficacy of Xuezhikang or atorvastatin on vascular function protection in hypertensive patients at low/moderate cardiovascular risk.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Xuezhikang	Xuezhikang
DRUG	Atorvastatin	Atorvastatin
BEHAVIORAL	Lifestyle modification	Lifestyle modification

Timeline

• Start date: 2013-10-01
• Primary completion: 2015-10-01
• Completion: 2016-10-01
• First posted: 2014-10-02
• Last updated: 2014-10-02

Locations

1 site across 1 country: China